Fullerton Health could turn to courts for rescue as woes mount and white knight seems elusive
SINGAPORE'S troubled Fullerton Healthcare (Fullerton Health) could be left with little option but to go down the judicial management (JM) path as time runs out and a sour shareholder stand-off jeopardises any potential sale to rescue the private healthcare solutions firm.
"Clearly, the (sale) process has gone on for very long with a lot of names thrown around... this sale has not materialised for various reasons and this has led to this whole conversation on JM," a reliable source told The Business Times (BT).
Fullerton Health, a "pan-regional platform" that offers corporations everything from health insurance plans and access to a network of healthcare providers to benefit plans, and also provides primary care and diagnostics, counts Hong Kong-based private equity (PE) firm RRJ Capital as its largest creditor.
KEYWORDS IN THIS ARTICLE
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
‘No better player’ than GIC to help revitalise fortunes of Singapore stock market: observers
Businessmen in Singapore placed on China’s wanted list weeks after money laundering raid in 2023
Stocks to watch: NetLink NBN Trust, Centurion, No Signboard
Chinese EV giants hammered by Biden tariff are welcome in Brazil
Hong Kong’s shaky crypto ETF debuts dent global hub aspirations
OpenAI, Reddit sign partnership on ChatGPT, AI products, ads